Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1223

1.

Health Care Resource Utilization and Costs Associated With Switching Biologics in Rheumatoid Arthritis.

Vanderpoel J, Tkacz J, Brady BL, Ellis L.

Clin Ther. 2019 Jun;41(6):1080-1089.e5. doi: 10.1016/j.clinthera.2019.04.032. Epub 2019 May 20.

PMID:
31122662
2.

Real-world incidence of inflammatory bowel disease among patients with other chronic inflammatory diseases treated with interleukin-17a or phosphodiesterase 4 inhibitors.

Emond B, Ellis LA, Chakravarty SD, Ladouceur M, Lefebvre P.

Curr Med Res Opin. 2019 Jun 6:1-9. doi: 10.1080/03007995.2019.1620713. [Epub ahead of print]

PMID:
31106607
3.

Glucocorticoid receptor expression in the stress-limbic circuitry is differentially affected by prenatal alcohol exposure and adolescent stress.

Raineki C, Morgan EJ, Ellis L, Weinberg J.

Brain Res. 2019 Sep 1;1718:242-251. doi: 10.1016/j.brainres.2019.05.019. Epub 2019 May 15.

PMID:
31102593
4.

Assessing the appropriateness of the management of upper respiratory tract infection in Australian children: a population-based sample survey.

Long JC, Williams HM, Jani S, Arnolda G, Ting HP, Molloy CJ, Hibbert PD, Churruca K, Ellis LA, Braithwaite J.

BMJ Open. 2019 May 14;9(5):e026915. doi: 10.1136/bmjopen-2018-026915.

5.

How people fit in at work: systematic review of the association between person-organisation and person-group fit with staff outcomes in healthcare.

Herkes J, Churruca K, Ellis LA, Pomare C, Braithwaite J.

BMJ Open. 2019 May 9;9(5):e026266. doi: 10.1136/bmjopen-2018-026266.

6.

Differential Expression and Localization of Branchial AQP1 and AQP3 in Japanese Medaka (Oryzias latipes).

Ellis LV, Bollinger RJ, Weber HM, Madsen SS, Tipsmark CK.

Cells. 2019 May 8;8(5). pii: E422. doi: 10.3390/cells8050422.

7.

The Mortality-to-Incidence Ratio Is Not a Valid Proxy for Cancer Survival.

Ellis L, Belot A, Rachet B, Coleman MP.

J Glob Oncol. 2019 May;5:1-9. doi: 10.1200/JGO.19.00038.

8.

Outcomes of infliximab dose escalation in patients with rheumatoid arthritis.

Cohen SB, Kremer JM, Dandreo KJ, Reed GW, Magner R, Shan Y, Kafka S, DeHoratius RJ, Ellis L, Parenti D.

Clin Rheumatol. 2019 May 2. doi: 10.1007/s10067-019-04543-z. [Epub ahead of print]

PMID:
31049762
9.

Comment on "A Roadmap for Aspiring Surgeon-Scientists in Today's Healthcare Environment".

Vega EA, Ellis LM.

Ann Surg. 2019 Apr 23. doi: 10.1097/SLA.0000000000003334. [Epub ahead of print] No abstract available.

PMID:
31021829
10.

Underlying liver disease and advanced stage liver cancer are associated with elevated neutrophil-lymphocyte ratio.

Wong L, Bozhilov K, Hernandez B, Kwee S, Chan O, Ellis L, LeMarchand L.

Clin Mol Hepatol. 2019 Apr 19. doi: 10.3350/cmh.2019.0004. [Epub ahead of print]

11.

Inflammatory biomarkers, geriatric assessment, and treatment outcomes in acute myeloid leukemia.

Loh KP, Tooze JA, Nicklas BJ, Kritchevsky SB, Williamson JD, Ellis LR, Powell BL, Pardee TS, Goyal NG, Klepin HD.

J Geriatr Oncol. 2019 Apr 5. pii: S1879-4068(19)30041-4. doi: 10.1016/j.jgo.2019.03.014. [Epub ahead of print]

PMID:
30962090
12.

Single and Synergistic Effects of Cannabidiol and Δ-9-Tetrahydrocannabinol on Zebrafish Models of Neuro-Hyperactivity.

Samarut É, Nixon J, Kundap UP, Drapeau P, Ellis LD.

Front Pharmacol. 2019 Mar 20;10:226. doi: 10.3389/fphar.2019.00226. eCollection 2019.

13.

Comprehensive Researcher Achievement Model (CRAM): a framework for measuring researcher achievement, impact and influence derived from a systematic literature review of metrics and models.

Braithwaite J, Herkes J, Churruca K, Long JC, Pomare C, Boyling C, Bierbaum M, Clay-Williams R, Rapport F, Shih P, Hogden A, Ellis LA, Ludlow K, Austin E, Seah R, McPherson E, Hibbert PD, Westbrook J.

BMJ Open. 2019 Mar 30;9(3):e025320. doi: 10.1136/bmjopen-2018-025320.

14.

Scientific Integrity and Data Accuracy.

Disis MLN, Ellis LM.

JAMA Oncol. 2019 Mar 28. doi: 10.1001/jamaoncol.2019.0656. [Epub ahead of print] No abstract available.

PMID:
30920610
15.

The influence of complexity: a bibliometric analysis of complexity science in healthcare.

Churruca K, Pomare C, Ellis LA, Long JC, Braithwaite J.

BMJ Open. 2019 Mar 23;9(3):e027308. doi: 10.1136/bmjopen-2018-027308.

16.

Inhibition of PGE2/EP4 receptor signaling enhances oxaliplatin efficacy in resistant colon cancer cells through modulation of oxidative stress.

Huang H, Aladelokun O, Ideta T, Giardina C, Ellis LM, Rosenberg DW.

Sci Rep. 2019 Mar 20;9(1):4954. doi: 10.1038/s41598-019-40848-4.

17.

Discovery of Soft-Drug Topical Tool Modulators of Sphingosine-1-phosphate Receptor 1 (S1PR1).

Bell M, Foley D, Naylor C, Wood G, Robinson C, Riley J, Epemolu O, Ellis L, Scullion P, Shishikura Y, Osuna-Cabello M, Ferguson L, Pinto E, Fletcher D, Katz E, McLean WHI, Wyatt P, Read KD, Woodland A.

ACS Med Chem Lett. 2019 Feb 14;10(3):341-347. doi: 10.1021/acsmedchemlett.8b00616. eCollection 2019 Mar 14.

18.

Mediterranean-style diet for the primary and secondary prevention of cardiovascular disease.

Rees K, Takeda A, Martin N, Ellis L, Wijesekara D, Vepa A, Das A, Hartley L, Stranges S.

Cochrane Database Syst Rev. 2019 Mar 13;3:CD009825. doi: 10.1002/14651858.CD009825.pub3.

PMID:
30864165
19.

Understanding the priorities of residents, family members and care staff in residential aged care using Q methodology: a study protocol.

Ludlow K, Churruca K, Ellis LA, Mumford V, Braithwaite J.

BMJ Open. 2019 Mar 7;9(3):e027479. doi: 10.1136/bmjopen-2018-027479.

20.

Intensified therapies improve survival and identification of novel prognostic factors for placental-site and epithelioid trophoblastic tumours.

Froeling FEM, Ramaswami R, Papanastasopoulos P, Kaur B, Sebire NJ, Short D, Fisher RA, Sarwar N, Wells M, Singh K, Ellis L, Horsman JM, Winter MC, Tidy J, Hancock BW, Seckl MJ.

Br J Cancer. 2019 Mar;120(6):587-594. doi: 10.1038/s41416-019-0402-0. Epub 2019 Feb 22.

PMID:
30792530
21.

Building a learning community of Australian clinical genomics: a social network study of the Australian Genomic Health Alliance.

Long JC, Pomare C, Best S, Boughtwood T, North K, Ellis LA, Churruca K, Braithwaite J.

BMC Med. 2019 Feb 22;17(1):44. doi: 10.1186/s12916-019-1274-0.

22.

Physician attitudes about non-medical switching to biosimilars: results from an online physician survey in the United States.

Teeple A, Ellis LA, Huff L, Reynolds C, Ginsburg S, Howard L, Walls D, Curtis JR.

Curr Med Res Opin. 2019 Apr;35(4):611-617. doi: 10.1080/03007995.2019.1571296. Epub 2019 Feb 4.

PMID:
30712393
23.

Safe Food Management and Smartphone Technology: Investigating the Impact of an App on Consumer Knowledge Retention.

Bamgboje-Ayodele A, Ellis L, Turner P.

Online J Public Health Inform. 2018 Dec 30;10(3):e222. doi: 10.5210/ojphi.v10i3.9542. eCollection 2018.

24.

Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab.

Ellis LA, Malangone-Monaco E, Varker H, Stetsovsky D, Kubacki M, DeHoratius RJ, Kafka S.

Clinicoecon Outcomes Res. 2019 Jan 15;11:99-110. doi: 10.2147/CEOR.S185547. eCollection 2019.

25.

Consideration of Potential Drug-Drug Interactions in Selection of FDA-Approved Drugs Indicated for Prostate Cancer.

Pilon D, Ellis LA, Xiao Y, Behl AS, Lefebvre P.

Am J Ther. 2019 May/Jun;26(3):e422-e424. doi: 10.1097/MJT.0000000000000693. No abstract available.

PMID:
30677005
26.

ONECUT2 is a driver of neuroendocrine prostate cancer.

Guo H, Ci X, Ahmed M, Hua JT, Soares F, Lin D, Puca L, Vosoughi A, Xue H, Li E, Su P, Chen S, Nguyen T, Liang Y, Zhang Y, Xu X, Xu J, Sheahan AV, Ba-Alawi W, Zhang S, Mahamud O, Vellanki RN, Gleave M, Bristow RG, Haibe-Kains B, Poirier JT, Rudin CM, Tsao MS, Wouters BG, Fazli L, Feng FY, Ellis L, van der Kwast T, Berlin A, Koritzinsky M, Boutros PC, Zoubeidi A, Beltran H, Wang Y, He HH.

Nat Commun. 2019 Jan 17;10(1):278. doi: 10.1038/s41467-018-08133-6.

27.

Patient attitudes about non-medical switching to biosimilars: results from an online patient survey in the United States.

Teeple A, Ginsburg S, Howard L, Huff L, Reynolds C, Walls D, Ellis LA, Curtis JR.

Curr Med Res Opin. 2019 Apr;35(4):603-609. doi: 10.1080/03007995.2018.1560221. Epub 2019 Jan 8.

PMID:
30618353
28.

The Reality of Uncertainty in Mental Health Care Settings Seeking Professional Integration: A Mixed-Methods Approach.

Pomare C, Ellis LA, Churruca K, Long JC, Braithwaite J.

Int J Integr Care. 2018 Dec 19;18(4):13. doi: 10.5334/ijic.4168.

29.

Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer.

Zadra G, Ribeiro CF, Chetta P, Ho Y, Cacciatore S, Gao X, Syamala S, Bango C, Photopoulos C, Huang Y, Tyekucheva S, Bastos DC, Tchaicha J, Lawney B, Uo T, D'Anello L, Csibi A, Kalekar R, Larimer B, Ellis L, Butler LM, Morrissey C, McGovern K, Palombella VJ, Kutok JL, Mahmood U, Bosari S, Adams J, Peluso S, Dehm SM, Plymate SR, Loda M.

Proc Natl Acad Sci U S A. 2019 Jan 8;116(2):631-640. doi: 10.1073/pnas.1808834116. Epub 2018 Dec 21.

30.

The future of health systems to 2030: a roadmap for global progress and sustainability.

Braithwaite J, Mannion R, Matsuyama Y, Shekelle PG, Whittaker S, Al-Adawi S, Ludlow K, James W, Ting HP, Herkes J, McPherson E, Churruca K, Lamprell G, Ellis LA, Boyling C, Warwick M, Pomare C, Nicklin W, Hughes CF.

Int J Qual Health Care. 2018 Dec 1;30(10):823-831. doi: 10.1093/intqhc/mzy242.

PMID:
30576556
31.

Metastatic inflammatory myofibroblastic tumor of the bladder.

Libby EK, Ellis LT, Weinstein S, Hammer RD, Murray KS.

Urol Case Rep. 2018 Nov 15;23:10-12. doi: 10.1016/j.eucr.2018.11.007. eCollection 2019 Mar.

32.

Analysis of real-world treatment patterns in a matched rheumatology population that continued innovator infliximab therapy or switched to biosimilar infliximab.

Yazici Y, Xie L, Ogbomo A, Ellis LA, Goyal K, Teeple A, Simsek I.

Biologics. 2018 Oct 25;12:127-134. doi: 10.2147/BTT.S172337. eCollection 2018.

33.

Managers' perceptions of the effects of a national mandatory accreditation program in Danish hospitals. A cross-sectional survey.

Nicolaisen A, Bogh SB, Churruca K, Ellis LA, Braithwaite J, von Plessen C.

Int J Qual Health Care. 2019 Jun 1;31(5):331-337. doi: 10.1093/intqhc/mzy174.

PMID:
30476098
34.

A revised model of uncertainty in complex healthcare settings: A scoping review.

Pomare C, Churruca K, Ellis LA, Long JC, Braithwaite J.

J Eval Clin Pract. 2019 Apr;25(2):176-182. doi: 10.1111/jep.13079. Epub 2018 Nov 22. Review.

PMID:
30467915
35.

TIGA-CUB-manualised psychoanalytic child psychotherapy versus treatment as usual for children aged 5-11 with treatment-resistant conduct disorders and their primary carers: results from a randomised controlled feasibility trial.

Edginton E, Walwyn R, Twiddy M, Wright-Hughes A, Tubeuf S, Reed S, Smith A, Stubbs L, Birtwistle J, Abraham SJ, Ellis L, Midgley N, Hughes T, Wallis P, Cottrell D.

J Child Adolesc Ment Health. 2018 Nov;30(3):167-182. doi: 10.2989/17280583.2018.1532433. Epub 2018 Nov 14.

36.

Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2.

Chang K, Willis JA, Reumers J, Taggart MW, San Lucas FA, Thirumurthi S, Kanth P, Delker DA, Hagedorn CH, Lynch PM, Ellis LM, Hawk ET, Scheet PA, Kopetz S, Arts J, Guinney J, Dienstmann R, Vilar E.

Ann Oncol. 2018 Oct 1;29(10):2061-2067. doi: 10.1093/annonc/mdy337.

PMID:
30412224
37.

Interprofessional collaboration in mental health settings: a social network analysis.

Pomare C, Long JC, Ellis LA, Churruca K, Braithwaite J.

J Interprof Care. 2018 Nov 9:1-7. doi: 10.1080/13561820.2018.1544550. [Epub ahead of print]

PMID:
30411988
38.

Assessment of Reported Trial Characteristics, Rate of Publication, and Inclusion of Mandatory Biopsies of Research Biopsies in Clinical Trials in Oncology.

Parseghian CM, Tam AL, Yao J, Ensor J Jr, Ellis LM, Raghav K, Overman MJ.

JAMA Oncol. 2018 Nov 1. doi: 10.1001/jamaoncol.2018.4640. [Epub ahead of print]

PMID:
30383128
39.

Role of corticosterone in anxiety- and depressive-like behavior and HPA regulation following prenatal alcohol exposure.

Lam VYY, Raineki C, Wang LY, Chiu M, Lee G, Ellis L, Yu W, Weinberg J.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 2;90:1-15. doi: 10.1016/j.pnpbp.2018.10.008. Epub 2018 Oct 24.

PMID:
30367959
40.

A descriptive analysis of real-world treatment patterns of innovator (Remicade®) and biosimilar infliximab in an infliximab-naïve Turkish population.

Yazici Y, Xie L, Ogbomo A, Ellis LA, Goyal K, Teeple A, Mutlu EA, Simsek I.

Biologics. 2018 Oct 2;12:97-106. doi: 10.2147/BTT.S172241. eCollection 2018.

41.

Normothermic versus hypothermic cardiopulmonary bypass in low-risk paediatric heart surgery: a randomised controlled trial.

Caputo M, Pike K, Baos S, Sheehan K, Selway K, Ellis L, Stoica S, Parry A, Clayton G, Culliford L, Angelini GD, Pandey R, Rogers CA.

Heart. 2019 Mar;105(6):455-464. doi: 10.1136/heartjnl-2018-313567. Epub 2018 Oct 15.

42.

Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma.

Purzner T, Purzner J, Buckstaff T, Cozza G, Gholamin S, Rusert JM, Hartl TA, Sanders J, Conley N, Ge X, Langan M, Ramaswamy V, Ellis L, Litzenburger U, Bolin S, Theruvath J, Nitta R, Qi L, Li XN, Li G, Taylor MD, Wechsler-Reya RJ, Pinna LA, Cho YJ, Fuller MT, Elias JE, Scott MP.

Sci Signal. 2018 Sep 11;11(547). pii: eaau5147. doi: 10.1126/scisignal.aau5147.

43.

Clinical efficacy of eplerenone versus placebo for central serous chorioretinopathy: study protocol for the VICI randomised controlled trial.

Willcox A, Culliford L, Ellis L, Rogers CA, Cree A, Chakravarthy U, Ennis S, Behar-Cohen F, Reeves BC, Sivaprasad S, Lotery A.

Eye (Lond). 2019 Feb;33(2):295-303. doi: 10.1038/s41433-018-0212-2. Epub 2018 Sep 7.

44.

Endothelial Cells Promote Colorectal Cancer Cell Survival by Activating the HER3-AKT Pathway in a Paracrine Fashion.

Wang R, Bhattacharya R, Ye X, Fan F, Boulbes DR, Ellis LM.

Mol Cancer Res. 2019 Jan;17(1):20-29. doi: 10.1158/1541-7786.MCR-18-0341. Epub 2018 Aug 21.

PMID:
30131447
45.

Colorectal Cancer Incidence Trends by Age, Stage, and Racial/Ethnic Group in California, 1990-2014.

Ellis L, Abrahão R, McKinley M, Yang J, Somsouk M, Marchand LL, Cheng I, Gomez SL, Shariff-Marco S.

Cancer Epidemiol Biomarkers Prev. 2018 Sep;27(9):1011-1018. doi: 10.1158/1055-9965.EPI-18-0030. Epub 2018 Aug 16.

PMID:
30115679
46.

Prenatal alcohol exposure disrupts male adolescent social behavior and oxytocin receptor binding in rodents.

Holman PJ, Ellis L, Morgan E, Weinberg J.

Horm Behav. 2018 Sep;105:115-127. doi: 10.1016/j.yhbeh.2018.08.004. Epub 2018 Aug 16.

PMID:
30110605
47.

Synthesis and characterization of Zr- and Hf-doped nano-TiO2 as internal standards for analytical quantification of nanomaterials in complex matrices.

Ellis LA, Papadiamantis AG, Weigel S, Valsami-Jones E.

R Soc Open Sci. 2018 Jun 6;5(6):171884. doi: 10.1098/rsos.171884. eCollection 2018 Jun.

48.

Understanding the Limitations of Cancer Registry Insurance Data-Implications for Policy-Reply.

Ellis L, Lichtensztajn D, Gomez SL.

JAMA Oncol. 2018 Oct 1;4(10):1433-1434. doi: 10.1001/jamaoncol.2018.2460. No abstract available.

PMID:
30054606
49.

An Australian Perspective.

Freemantle J, Ellis L.

In: Duncan JR, Byard RW, editors. SIDS Sudden Infant and Early Childhood Death: The Past, the Present and the Future. Adelaide (AU): University of Adelaide Press; 2018 May. Chapter 16.

50.

What drives using antibiotic without prescriptions? A qualitative interview study of university students in United Arab Emirates.

Al-Kubaisi KA, De Ste Croix M, Vinson D, Ellis L, Sharif SI, Abduelkarem AR.

Pharm Pract (Granada). 2018 Apr-Jun;16(2):1172. doi: 10.18549/PharmPract.2018.02.1172. Epub 2018 Jun 27. Erratum in: Pharm Pract (Granada). 2018 Jul-Sep;16(3):1326.

Supplemental Content

Support Center